Cargando…

Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations

A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The Anti–SARS‐CoV‐2 Repurposing Drug Database is a database that includes both in vitro anti–SARS‐CoV‐2 activity and in vivo pharmacokinetic data to f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xinyuan, Yang, Yuching, Grimstein, Manuela, Liu, Guansheng, Kitabi, Eliford, Fan, Jianghong, Wang, Ying‐Hong, Earp, Justin, Weaver, James L., Zhu, Hao, Liu, Jiang, Reynolds, Kellie S., Huang, Shiew‐Mei, Wang, Yaning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420371/ https://www.ncbi.nlm.nih.gov/pubmed/34218521 http://dx.doi.org/10.1002/psp4.12681

Ejemplares similares

Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation
por: Kuemmel, Colleen, et al.
Publicado: (2019)

A regulatory science viewpoint on botanical–drug interactions
por: Grimstein, Manuela, et al.
Publicado: (2018)

Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
por: Jean, Daphney, et al.
Publicado: (2021)

Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration
por: Bai, Jane P. F., et al.
Publicado: (2021)

Optimal single sampling time-point for monitoring of praziquantel exposure in children
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2021)

Genetic and non‐genetic factors influencing efavirenz population pharmacokinetics among human immunodeficiency virus‐1‐infected children in Ethiopia
por: Chala, Adugna, et al.
Publicado: (2023)

Considerations and challenges for sex-aware drug repurposing
por: Fisher, Jennifer L., et al.
Publicado: (2022)

Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype
por: Kitabi, Eliford Ngaimisi, et al.
Publicado: (2018)

Predictors of Efavirenz Plasma Exposure, Auto-Induction Profile, and Effect of Pharmacogenetic Variations among HIV-Infected Children in Ethiopia: A Prospective Cohort Study
por: Chala, Adugna, et al.
Publicado: (2021)

Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends
por: Liu, Qi, et al.
Publicado: (2021)

Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether–lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial
por: Mhamilawa, Lwidiko E., et al.
Publicado: (2020)

Emerging Role of Organ‐on‐a‐Chip Technologies in Quantitative Clinical Pharmacology Evaluation
por: Isoherranen, Nina, et al.
Publicado: (2019)

Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps
por: INO, HIROYASU, et al.
Publicado: (2020)

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
por: Liu, Dan-Yang, et al.
Publicado: (2021)

Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
por: Lourenço, Tânia, et al.
Publicado: (2023)

Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma
por: Weng, Ningna, et al.
Publicado: (2022)

ReDO_DB: the repurposing drugs in oncology database
por: Pantziarka, Pan, et al.
Publicado: (2018)

A Database of Drug Repurposing Clinical Trials in Oncology
por: Pantziarka, Pan, et al.
Publicado: (2021)

Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities
por: Dinh, Jean, et al.
Publicado: (2023)

A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development
por: Bai, Jane P. F., et al.
Publicado: (2020)

Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches
por: Batalha, Pedro N., et al.
Publicado: (2021)

The pharmacological bases for repurposing statins in depression: a review of mechanistic studies
por: De Giorgi, Riccardo, et al.
Publicado: (2023)

N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2023)

Exploration of databases and methods supporting drug repurposing: a comprehensive survey
por: Tanoli, Ziaurrehman, et al.
Publicado: (2020)

Pregnancy and COVID‐19: pharmacologic considerations
por: D'Souza, R., et al.
Publicado: (2021)

Diabetic Retinopathy: A Pharmacological Consideration
por: Maheshwari, Saket Y, et al.
Publicado: (2023)

Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
por: Albiñana, Virginia, et al.
Publicado: (2020)

Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden
por: Bai, Jane P.F.
Publicado: (2016)

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
por: Kröker, Alina, et al.
Publicado: (2021)

Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
por: Alegría-Arcos, Melissa, et al.
Publicado: (2022)

Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
por: Liu, Tsang-Pai, et al.
Publicado: (2018)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology
por: Zhao, Zheng, et al.
Publicado: (2016)

Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2018)

Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
por: Thomas, Shilu Deepa, et al.
Publicado: (2022)

Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review
por: Witham, Miles D., et al.
Publicado: (2023)

Repurposing Azithromycin for Neonatal Neuroprotection
por: Barks, John D.E., et al.
Publicado: (2019)

Repurposing Clemastine to Target Glioblastoma Cell Stemness
por: Sun, Michael A., et al.
Publicado: (2023)

Testing bias in clinical databases: methodological considerations
por: Velthove, Karin J, et al.
Publicado: (2010)

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
por: Vohra, Manik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q8tncvg074np039sdk8bsn6in6